Shaping The Future Of Healthcare

Share

Pandemics, Globalization, and How To Improve Healthcare through Innovation and Digitalization with Noel Yeo, MD | Christoph Zindel

Season 1, Ep. 6

In an increasingly globalized world, viral spread has been difficult to avoid. Large numbers of people are moving constantly from place to place for business and leisure, and as economic prosperity grows, movement follows suit. While we can’t prevent pandemics from happening, we can learn how to manage them better. With experience comes innovation. 


Today, Managing Board Member Christoph Zindel interviews Dr. Noel Yeo, the Senior Vice President of one of Asia’s largest integrated private healthcare groups, Parkway Hospitals in Singapore at Parkway Pantai. Dr. Yeo has an Executive Master of Business Administration, a Postgraduate Certificate in Medical Law and Ethics, and an Executive Diploma in Directorship. He has been leading the group as their hospital facilities have battled the SARS-CoV-2 outbreak.

In this episode, Dr. Yeo tells us what it’s been like working through the COVID-19 pandemic at his hospital in Singapore. Having dealt with the SARS-CoV-1 outbreak back in 2003, Dr. Yeo provides valuable insights from that experience. We’ll talk about what he’s learned, how hospitals can prepare for future outbreaks, and the innovations that have resulted from these experiences. Dr. Yeo also talks about the importance of digitalization, and why a more patient-centric model of healthcare that leans towards prevention is the way of the future. 


Some Questions Asked:

  • Having experienced another outbreak in 2003, was Singapore better prepared than other countries? (1:53)
  • Are applications being used in Singapore to help with contact tracing? (7:27)
  • How has the backlog of elective procedures been dealt with in Singapore? (16:50)
  • How do you prepare for the next pandemic? (20:13)
  • Do you expect the beds and resources used to remain beyond this pandemic waiting for the next one? (25:22)
  • How are standard operating procedures dealt with, in such a large network? (29:53)


What You’ll Learn in This Episode:

  • The 3 point strategy used to confront SARS-CoV-2 (4:26)
  • How SARS-CoV-2 spread among the population in Singapore (15:07)
  • Plans for mass testing when the next wave hits (21:16)
  • Predictions about future healthcare challenges in Asia and beyond (33:26)
  • How we can use the abundance of data in healthcare to our advantage (37:22)
  • One helpful innovation that is being used at Parkway Pantai (39:00)


Connect with Dr. Noel Yeo:

 

Connect with our Managing Board Member, Christoph Zindel: 

More Episodes

9/15/2021

Integrated Diagnostics and the Collaborative Future of Medicine with Prof. Dr. Stefan Schönberg | Christoph Zindel

Season 1, Ep. 14
One of the biggest beneficiaries of technological advancements has been the field of medicine. While vaccines to stop previous pandemics took decades to develop, multiple COVID-19 vaccines were developed within a much shorter time frame. Increased collaboration between players in the industry and those in the tech world promises even more advancements in the near future.In this episode, Managing Board Member Christoph Zindel is joined by Stefan Schönberg, MD, director and chairman of the department of radiology and nuclear medicine at the University Medical Center Mannheim. He is former President of the German Roentgen Society and a strong proponent of integrated diagnostics.In today’s conversation, you’ll hear about integrated diagnostics and the benefits that come with it. You’ll learn about the advancements that are being made and the existing gaps that need to be closed to take the medical industry to the next level. You’ll also learn about the role that AI has in advancing diagnostics, treatment, and prevention of diseases. Lastly, we’ll discuss the role of data in medical research and the current barriers to federated learning and research.Some Questions Asked:Can you give us a glimpse of integrated diagnostics at University Hospital in Mannheim? (01:11)Do you see circulating free DNA being used in early cancer detection? (08:39)Do you believe that integrated diagnostic influences therapeutic decisions? (12:33)How do you promote cultural change connected to integrated diagnostics? (21:45)What You’ll Learn in This Episode:How integrated diagnostic can be used to understand a disease’s trajectory (05:56)What is needed to make integrated diagnostic a success (11:01)The role of the digital twin in integrated diagnostics (16:31)How federated learning evidence can accelerate medical research (18:58)Connect with Prof. Dr. Stefan Schönberg:University Hospital MannheimConnect with our Managing Board Member, Christoph Zindel:LinkedIn
7/20/2021

The Importance of Radiology in Developing Nations with Dr. Suresh de Silva | Christoph Zindel

Season 1, Ep. 13
Economic disparities around the world are an unfortunate reality. The past year has made it clearer than ever that the availability of quality healthcare for everyone benefits the whole. Globalization has forged a connection that strengthens our sense of humanity. With that sentiment in mind, it’s important that those who can help recognize that they bear a responsibility to lift up the whole.In this episode, Managing Board Member Christoph Zindel talks to Dr. Suresh de Silva, founder of Radiology Across Borders, a global charity that provides education and programs in radiology to help save lives in developing nations. Dr. de Silva is a fellow of the Royal Australian and New Zealand College of Radiologists and also an Adjunct Senior Lecturer at UNSW and an Oncological/Urological radiologist.In today’s conversation, you’ll hear about the positive global impact of Dr. Suresh de Silva’s organization, Radiology Across Borders. Their numerous projects are helping not only with treatment, but also with screening and prevention in populations that need greater access to medical technology and care. You’ll also hear important perspectives on the impact and future possibilities of AI in medical care. Additionally, the conversation covers the realities of starting a global charity from the ground up, and delves into the mindset of a founder who has successfully made an impact on countless lives around the world.Some Questions Asked:What projects are you currently focused on? (9:21)What's your vision of the role of AI-supported radiology in the future? (17:43)How can other organizations learn from Radiology Across Borders? (26:27)How have you been affected privately and professionally by this pandemic? (34:56)What You’ll Learn in This Episode:The important role radiology plays in healthcare (4:52)The biggest potential impact of AI (20:51)The realities of creating a charity organization (29:15)Comparing the differences between recent pandemics (37:20)Connect with Dr. Suresh de Silva:LinkedInConnect with our Managing Board Member, Christoph Zindel:LinkedIn
5/5/2021

How Do Coronavirus Variants Affect our Immune System, and How Can We Protect our Vulnerable?

Season 1, Ep. 12
We’ve come a long way in our understanding of SARS-CoV-2. Since the first cases were reported in late 2019, the rapid spread of the virus required quick thinking, thorough communication across the globe, and immediate action within the medical community. SARS-CoV-2 spread rapidly and began mutating differently all over the world. Tracking, testing, and treatment options had to keep pace. We needed information quickly in order to treat people effectively and protect our most vulnerable.Today, Siemens Healthineers President of Laboratory Diagnostics, Deepak Nath is joined by Dr. Ankur Mutreja, a global health scientist from the University of Cambridge, and Dr. Kevin Latinis, a clinical Rheumatologist with a practice in Missouri. Their experiences throughout the SARS-CoV-2 outbreak will help us understand how the virus continues to mutate globally, why viruses mutate, and how early antibody testing helped us to understand the ability of this virus to spread at such an advanced pace.In this episode, you’ll hear about the known variants of SARS-CoV-2, how our immune systems respond through these mutations, and why names matter. We’ll also rewind back to the beginning of the pandemic and hear about some of the earliest serology tests that took place in a Missouri nursing home, and how that timely information helped us understand how the virus spread.Some Questions Asked:What consequences can naming variants after countries or regions have? (2:09)Could a new variant emerge that effectively sets us back to square one? (4:14)How can vaccine development keep pace with these variants? (9:13)Why use antibody tests? (15:18)How can we take care of our most vulnerable? (19:49)What are the next steps for data collection? (22:39)What You’ll Learn in This Episode:Why new variants of the virus continue to be discovered (2:59)Protection levels against new variants from antibodies and the vaccine (4:54)Why mutations occur and when we need to be concerned about them (5:51)What we learned from an early study of antibodies (14:23)How antibody tests work, and what they can tell us (17:30)How one doctor is helping patients feel comfortable with vaccines (21:02)Connect with Ankur Mutreja:LinkedInConnect with Kevin Latinis:LinkedInYoutubeConnect with Katherine Soreng:LinkedInConnect with Deepak Nath:LinkedInTwitter